Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2015, Article ID 796871, 9 pages
http://dx.doi.org/10.1155/2015/796871
Research Article

Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT

Department of Endocrinology and Internal Medicine, THG, Aarhus University Hospital, 8000 Aarhus C, Denmark

Received 13 March 2015; Accepted 22 June 2015

Academic Editor: Massimo Tonacchera

Copyright © 2015 Emil Moser et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Blum, D. C. Bauer, T. Collet et al., “Subclinical Ttyroid dysfunction and fracture risk,” The Journal of the American Medical Association, vol. 313, no. 20, pp. 2055–2065, 2015. View at Publisher · View at Google Scholar
  2. D. Tuchendler and M. Bolanowski, “Assessment of bone metabolism in premenopausal females with hyperthyroidism and hypothyroidism,” Endokrynologia Polska, vol. 64, no. 1, pp. 40–44, 2013. View at Google Scholar · View at Scopus
  3. P. Vestergaard, L. Rejnmark, and L. Mosekilde, “Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk,” Calcified Tissue International, vol. 77, no. 3, pp. 139–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Ross, “Hyperthyroidism, thyroid hormone therapy, and bone,” Thyroid, vol. 4, no. 3, pp. 319–326, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Melsen and L. Mosekilde, “Morphometric and dynamic studies of bone changes in hyperthyroidism,” Acta Pathologica et Microbiologica Scandinavica—Section A Pathology, vol. 85, no. 2, pp. 141–150, 1977. View at Google Scholar · View at Scopus
  6. L. Mosekilde and F. Melsen, “Morphometric and dynamic studies of bone changes in hypothyroidism,” Acta Pathologica et Microbiologica Scandinavica Section A: Pathology, vol. 86, no. 1, pp. 56–62, 1978. View at Google Scholar · View at Scopus
  7. L. Mosekilde, E. F. Eriksen, and P. Charles, “Effects of thyroid hormones on bone and mineral metabolism,” Endocrinology and Metabolism Clinics of North America, vol. 19, no. 1, pp. 35–63, 1990. View at Google Scholar · View at Scopus
  8. J. M. Coindre, J. P. David, L. Riviere et al., “Bone loss in hypothyroidism with hormone replacement. A histomorphometric study,” Archives of Internal Medicine, vol. 146, no. 1, pp. 48–53, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. D. Bassett, A. Boyde, P. G. T. Howell et al., “Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 16, pp. 7604–7609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Williams, H. Robson, M. H. A. Kester et al., “Iodothyronine deiodinase enzyme activities in bone,” Bone, vol. 43, no. 1, pp. 126–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Rondeau and R. M. Tuttle, “Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States,” Seminars in Nuclear Medicine, vol. 41, no. 2, pp. 89–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Turner, X. Camacho, H. D. Fischer et al., “Levothyroxine dose and risk of fractures in older adults: nested case-control study,” British Medical Journal, vol. 342, no. 7805, Article ID d2238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Vestergaard and L. Mosekilde, “Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients,” Thyroid, vol. 12, no. 5, pp. 411–419, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. R. W. Flynn, S. R. Bonellie, R. T. Jung, T. M. MacDonald, A. D. Morris, and G. P. Leese, “Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 1, pp. 186–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Schneider, M. Schneider, C. Reiners, and P. Schneider, “Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. 3926–3934, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Affinito, C. Sorrentino, M. J. Farace et al., “Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism,” Acta Obstetricia et Gynecologica Scandinavica, vol. 75, no. 9, pp. 843–848, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Franklyn, J. Betteridge, J. Daykin et al., “Long-term thyroxine treatment and bone mineral density,” The Lancet, vol. 340, no. 8810, pp. 9–13, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Mosekilde, H. Beck-Nielsen, O. H. Sørensen et al., “Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women—results of the Danish Osteoporosis Prevention study,” Maturitas, vol. 36, no. 3, pp. 181–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Pistoia, B. van Rietbergen, E.-M. Lochmüller, C. A. Lill, F. Eckstein, and P. Rüegsegger, “Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images,” Bone, vol. 30, no. 6, pp. 842–848, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Murphy, C. C. Glüer, D. M. Reid et al., “Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 7, pp. 3173–3181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. M. van Der Deure, A. G. Uitterlinden, A. Hofman et al., “Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study,” Clinical Endocrinology, vol. 68, no. 2, pp. 175–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Roef, B. Lapauw, S. Goemaere et al., “Thyroid hormone status within the physiological range affects bone mass and density in healthy men at the age of peak bone mass,” European Journal of Endocrinology, vol. 164, no. 6, pp. 1027–1034, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Britto, A. J. Fenton, W. R. Holloway, and G. C. Nicholson, “Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption,” Endocrinology, vol. 134, no. 1, pp. 169–176, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kanatani, T. Sugimoto, H. Sowa, T. Kobayashi, M. Kanzawa, and K. Chihara, “Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction,” Journal of Cellular Physiology, vol. 201, no. 1, pp. 17–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Wojcicka, J. H. D. Bassett, and G. R. Williams, “Mechanisms of action of thyroid hormones in the skeleton,” Biochimica et Biophysica Acta, vol. 1830, no. 7, pp. 3979–3986, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Suwanwalaikorn, B. Ongphiphadhanakul, L. E. Braverman, and D. T. Baran, “Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats,” European Journal of Endocrinology, vol. 134, no. 5, pp. 655–659, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. T. L. Paul, J. Kerrigan, A. M. Kelly, L. E. Braverman, and D. T. Baran, “Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women,” The Journal of the American Medical Association, vol. 259, no. 21, pp. 3137–3141, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Mosekilde and F. Melsen, “A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism,” Acta Medica Scandinavica, vol. 204, no. 1-2, pp. 97–102, 1978. View at Google Scholar · View at Scopus
  29. L. Mosekilde and F. Melsen, “Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: bone histomorphometry,” Acta Endocrinologica, vol. 87, no. 4, pp. 751–758, 1978. View at Google Scholar · View at Scopus
  30. F. Melsen and L. Mosekilde, “Morphometric and dynamic studies of bone changes in hyperthyroidism,” Acta Pathologica et Microbiologica Scandinavica A, vol. 85, no. 2, pp. 141–150, 1977. View at Google Scholar · View at Scopus
  31. G. Roef, B. Lapauw, S. Goemaere et al., “Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men,” European Journal of Endocrinology, vol. 167, no. 5, pp. 719–726, 2012. View at Publisher · View at Google Scholar · View at Scopus